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Human peripheral blood mononuclear cell proliferation induced by Mycobacte-
rium leprae could be inhibited by the suppressor factor in the lysate of the
macrophages of lepromatous leprosy patients. Macrophages from normal subjects
and tuberculoid patients did not show production of a suppressor factor. Inhibi-
tion occurred only when the factor was present in the initial stages of lymphocyte
culture. The factor is heat stable and nondialyzable. Proliferation induced by
some mycobacteria and concanavalin A could also be blocked by the factor.
Interestingly, blastogenic response by a few other antigens and phytohemaggluti-
nin could not be inhibited by the suppressor factor. Mononuclear cells pretreated
with such lysate from lepromatous macrophages for 24 h could induce suppressive
activity in the cells in vitro in an autologous system. Treatment of these cells with
carbonyl iron after the induction phase, to remove phagocytic cells, did not
abolish their suppressive activity. The lepromatous macrophage lysate also
generated suppressive activity in a T-lymphocyte-enriched population of normal
subjects. These studies are interpreted to indicate that immunosuppression in
lepromatous patients is produced by both macrophages and T lymphocytes. The
exact phase in which either of these cells acts as a suppressor may be different.
Specific suppression by macrophages to M. leprae can be an early event, and
nonspecific suppression by T lymphocytes may be a later event in the course of
lepromatous leprosy.
Human leprosy exhibits a wide spectrum,
ranging from the tuberculoid type with high
immunity to the lepromatous type showing de-
pressed cell-mediated immunity. Attempts to
delineate the mechanisms of anergy in leproma-
tous leprosy have resulted in confficting data.
Early workers indicated a defective lymphocyte
population as being responsible for the low
immune response to Mycobacterium leprae in
lepromatous leprosy (8, 17). Hirschberg (11)
identified the lepromatous macrophage as being
the defective cell in leprosy. This was confirmed
in another study with HLA-matched individuals
(20). Our earlier studies (24) have also indicated
that an impairment in macrophage metabolism
could be responsible for lowered cell-mediated
immunity in lepromatous leprosy.
There is now growing evidence for the impor-
tance of suppressor cell-mediated immunoregu-
lation in mycobacterial infections (6, 14, 28).
Lepromin-induced reduction in response to
stimulation of leukocytes by concanavalin A
(ConA) has been reported in most lepromatous
patients (18). The authors have also indicated
that adherent cells and T cells are involved in
mediating this suppressor activity. Two types of
immunosuppressive populations have also been
identified in experimental murine leprosy infec-
tion (4). A direct requirement for both adherent
cells and T lymphocytes for inducing suppres-
sion in mycobacterial infections was suggested
by Wadee et al. (26).
In the present study we have investigated the
possibility of a macrophage-derived inhibitory
product negatively modulating lymphocyte pro-
liferation. The study of this product could make
it possible to examine the mechanism of immu-
nosuppression in an in vitro system.
MATERIALS AND METHODS
Subjects. Leprosy patients were classified according
to the Ridley and Jopling classification (22). Normal
controls were healthy volunteers, living in the same
environment, who may have had various degrees of
exposure to leprosy patients.
Antigens. M. leprae was harvested from nodules of
untreated lepromatous leprosy patients by a technique
developed earlier in our laboratory (1). Purified pro-
tein derivative (PPD) was obtained from the Staten
Serum Institute, Copenhagen, Denmark; Mycobacte-
rium bovis BCG was obtained from Glaxo Pharmaceu-
ticals Ltd., Greenford, England. Mycobacterium
avium, Mycobacterium intracellulare, Mycobacterium
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scrofulaceum, Mycobacterium kansasii, and Myco-
bacterium vaccae were cultivated in Middlebrook
7H10 medium. ICRC, a cultivable acid-fast isolate
obtained from a lepromatous nodule (2), was cultivat-
ed in Dubos medium. The bacilli were harvested in
their logarithmic phase.
Preparation of macrophage lysate. Macrophages
were cultivated in vitro from the blood of bacteriologi-
cally positive lepromatous leprosy patients by a meth-
od described in detail earlier (24). After 5 days in
culture, the macrophages were scraped off glass with a
rubber policeman. Cells were suspended in a known
volume of saline, and the cell count was determined.
The cells were exposed to six cycles of freezing and
thawing. Intracellular material thus released is re-
ferred to as lysate. Lysate thus obtained was passed
through a sterile Millipore filter (pore size, 0.22 pum;
Millipore Corp., New Bedford, Mass.) to remove cell
debris. Lysate was stored frozen until use. Leproma-
tous macrophage lysate is referred to, for conve-
nience, as LL lysate. Lysates from the macrophages
of tuberculoid patients (TT lysate) and normal volun-
teers (N lysate) were prepared as described above.
However, M. Ieprae was added in vitro to these
cultures before preparing the lysate so qs to simulate
as closely as possible the conditions prevailing in the
lepromatous leprosy patients. Lysates were also pre-
pared from macrophages of long-term-treated, bacil-
lus-negative lepromatous patients, with or without
adding M. leprae to the macrophages. The lysate
prepared without M. leprae is referred to as C-LL(-ve)
lysate, and lysate with added M. Ieprae is referred to
as ML-LL(-ve) lysate. Lysate was also made from
macrophage cultures after adding M. Ieprae and cyclo-
heximide. Cycloheximide was present during the en-
tire period of 48 h before lysate was prepared. LL
lysate was checked for heat stability at 56°C for 15 min
(H-LL lysate). LL lysate was dialyzed for 24 h in the
cold against distilled water. The dialysate is referred to
as D-LL lysate.
Nonspecific esterase. The method of Koski et al. (15)
was used for the identification of macrophages.
Lymphocyte proliferation assay. Mononuclear cells
from healthy individuals were separated over a Ficoll-
Triosil gradient. A cell count was taken and checked
for viability with trypan blue. The cell suspension was
adjusted to 106 cells per ml in culture medium (minimal
essential medium + 20% AB serum). A sample (100 pAl)
was distributed into each well of a microtiter plate, and
50 of antigen or mitogen was distributed into each of
the appropriate wells. Mitogen-treated cultures were
harvested on the third day, and antigen-exposed cul-
tures were harvested on the sixth day. Each culture
combination was prepared in triplicate. At 18 h before
the cultures were harvested, 0.5 puCi of [3H]thymidine
(specific activity, 9.8 Ci/mM) was added to each well.
Cells were harvested on fiber-glass filter disks, and
total thymidine incorporation was determined by the
liquid scintillation counting system. Results were ex-
pressed as counts per minute, calculated as experi-
mental counts per minute minus base-line counts per
minute. The concentrations of ConA and PPD used
were 8 and 4 pug/ml, respectively. The concentration of
phytohemagglutinin (PHA) used was 5 ,ug/ml. M.
leprae and the other mycobacteria were used at a dose
of 3 x 106 bacilli per ml.
Induction of suppressor cells. Mononuclear cells (3 x
106 cells per ml) in complete culture medium (minimal
essential medium + 20% AB serum) were incubated
with LL lysate (prepared from 3 x 10' cells) for 24 h at
37°C in a 5% CO2 atmosphere. Control cells were
incubated without LL lysate. After the induction, cells
were washed twice in minimal essential medium, sus-
pended in fresh medium, and incubated with 50 jig of
mitomycin-C (Sigma Chemical Co., St. Louis, Mo.)
per ml for 45 min at 37°C in a 5% CO2 atmosphere.
Cells were washed three times in minimal essential
medium and were suspended in complete medium at a
concentration of 106 cells per ml.
Responder cells. For autologous cultures, samples of
mononuclear cells from each subject were stored in
complete medium at 4°C during the induction period.
Cells were washed before use.
Suppressor assay. Assays were performed with flat-
bottomed microtiter plates. Experiments were per-
formed in triplicate, and each well contained 100 ,pl of
responder cells (105 cells) and 100 ,ul of suppressor or
control cells treated with mitomycin-C. Antigen or
mitogen was added to each well in 50-pul doses. Con-
centrations used were the same as those given above.
Plates were incubated at 37°C in 5% CO2 in air. At 18 h
before harvesting, 0.5 ,uCi [3H]thymidine was added to
each well. The cells were processed for scintillation
counting to determine total incorporation of thymi-
dine. Results were expressed as counts per minute,
calculated as the counts per minute of responder cells
in the presence of mitomycin-C-treated cells and the
stimulant minus the counts per minute of responder
cells in the presence of mitomycin-C-treated cells
alone.
Separation of phagocytic cells from the stimulator cell
population. Sterilized carbonyl iron (5 mg/ml) was
added to the LL lysate-induced suppressor cell popu-
lation. Cells were subsequently incubated at 37°C for
45 min, during which time they were agitated at 15-min
intervals. After incubation, the cells were again lay-
ered on Ficoll-Triosil to remove carbonyl iron-ingest-
ed cells. The iron-ingested cells settled to the bottom.
Cells at the interfase were collected and tested for
suppressor activity. Morphological examination by
light microscopy of the cells at the interfase showed
about 1% monocyte contamination. Before separation,
8 to 10o monocytes were present.
Separation of T lymphocytes and suppressor cell
induction. A T-lymphocyte-enriched population was
obtained from normal subjects by the nylon wool
column technique (9). The T-lymphocyte-enriched
population was exposed for 24 h to LL lysate and was
checked for inhibitory activity to ConA stimulation as
described above.
RESULTS
Effect of macrophage lysate on normal lympho-
cyte proliferation. When LL lysate was added to
normal mononuclear cell cultures activated with
M. leprae, substantial suppression of blastogen-
esis was observed. When TT lysate or N lysate
was added to the normal culture, no inhibition
was observed (Fig. 1). Macrophage lysate from
lepromatous patients negative for acid-fast bacil-
li when prepared without addition of M. leprae
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factor was nondialyzable, and moreover, the
-4----4--7factor retained its activity on being heated at
56°C for 15 min (Fig. 1).
Effect of addition of LL lysate to normal mono-
nuclear cell culture at different time intervals.
The lymphocyte proliferation assay permitted us
to explore the temporal events in the exposure
of lysate to normal mononuclear cell cultures for
iZ Is mediating the suppression. LL lysate was added
to mononuclear cell cultures at the initiation of
culture and at 24, 48, 72, and 96 h after culture
tns initiation. In all cases, [3H]thymidine was added
_____
96 h after the initiation of culture. It was ob-
served that inhibitory activity decreased as the
W. leprae as time interval of addition of the lysate to the
on of normal culture was delayed, inhibition being observed
s exposed to up to 48 h. The percentages of inhibition ob-
sate, dialyzed served at 0, 24, and 48 h were 60, 59, and 50%,
C for 15 min. respectively. At 72 h there was partial inhibition
osed to lysate (25.5%), after which no inhibition was observed
ative for acid- (Fig. 2). Apparently, suppressor factor activityd without [C- is manifested in early events associated with
samples and lymphocyte proliferation.
Specificity of action of LL lysate. We also
studied the specificity of the inhibition caused
by LL lysate. LL lysate significantly suppressed
ConA-mediated lymphocyte proliferation (Table
show inhibi- 2). Proliferation to mycobacterial antigens M.
leprae was scrofulaceum, M. avium, M. intracellulare, and
fs [ML-LL- M. kansasii was also blocked (Fig. 3). However,fhsuppressor blastogenesis induced by M. vaccae, M. bovisheximide to BCG, and PPD was not inhibited by the LL
leprae pre-
essor factor
tte prepared
prae had no
e inhibitory
TABLE 1. Effect of cycloheximide and autoclaved
M. leprae on the production of the inhibitory factor
in lepromatous macrophages
A cpm
pLL-lysate' Pcpm
1 2 3 4
C 3,608 8,242 3,670 5,098
ML 125 3,067 112 1,566 <0.0025
CY + ML 2,800 6,929 3,681 6,784 NSC
AML 3,512 8,126 3,427 5,001 NS
a Cells from normal healthy controls were stimulat-
ed with M. leprae in the presence of lysate of macro-
phages from lepromatous bacillus-negative patients
(C); lysate of macrophages from the same patient,
exposed to M. leprae in vitro (5 x 106 bacilli per ml)
for 48 h before the lysate was prepared (ML); lysate
prepared from macrophage cultures 48 h after cyclo-
heximide (1 ,ug/ml) and M. leprae were added (CY +
ML); and lysate prepared from macrophages treated
with autoclaved M. leprae for 48 hours (AML).
b Compared with values for C.
c NS, Not significant.
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FIG. 2. Effect of addition of LL lysate to normal
mononuclear cell cultures at various time intervals
ranging from 0 to 96 h after activation with M. leprae.
The percent difference was calculated as [(counts per
minute - control counts per minute)/(control counts
per minute)] x 100, where counts per minute repre-
sents the antigen-stimulated culture and experimental
counts per minute represents the culture stimulated
with antigens and LL lysate added at various time
intervals. 0, Mean value.
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lysate (Fig. 3). Normal lymphocyte blastogene-
sis to PHA was also not affected by LL lysate
(Table 2). In the five experiments with ICRC,
stimulation was inhibited by the LL lysate in
only one case (Fig. 3).
Ability of LL lysate to activate suppressor cells
in vitro. LL lysate was added to a normal
mononuclear cell culture to induce suppressor
activity. It was capable of inducing a suppressor
cell population when tested in coculture experi-
ments (Fig. 4 and 5). The level of suppression
was 67 ± 11% for the ConA response and 86 +
7% for the M. leprae response (Table 3). The
suppressor cells were nonspecific in their action
as they inhibited both ConA- and M. Ieprae-
mediated stimulation (Fig. 4 and 5). Mononucle-
ar cells of tuberculoid patients also showed
significant suppression in the presence of autolo-
gous cells treated with LL lysate (Fig. 4 and 5).
The level of suppression observed was 82 ± 11%
for the ConA response and 86 ± 11% for the M.
leprae response (Table 3). Results for long-term-
treated, bacillus-negative lepromatous patients
were similar to those for normal volunteers and
tuberculoid patients; when stimulated with
ConA, their mononuclear cells were also sup-
pressed in the presence of autologous cells pre-
treated for 24 h with LL lysate (Fig. 4 and Table
3). Suppressor activity in lepromatous patients
was tested with ConA stimulation only as their
response to M. leprae is never regained even
after long-term treatment. In lepromatous bacil-
lus-positive patients, response to M. leprae and
to ConA is very low; hence, when we tested for
suppressor activity, there were no increased
levels of suppression above those already pres-
ent (Table 4).
Effect of removal of phagocytic macrophages
from suppressor cell population on inhibitory
activity. Cells treated with LL lysate retained
their suppressive activity even after depletion of
the phagocytic cells. Suppression in the pres-
ence of LL lysate alone was 57% in controls; in
carbonyl iron-treated cells it was 50%. In the
FIG. 3. Effect of LL lysate on the proliferative
responses of normal mononuclear cells to various
mycobacteria. Data have been presented as increase
or suppression, calculated as [(counts per minute of
antigen + LL lysate culture - counts per minute of
antigen culture)/(counts per minute of antigen culture)]
x 100. M. intra, M. intracellulare; M. scrof, M.
scrofulaceum.
tuberculoid and lepromatous group, the corre-
sponding values were 77 and 73% suppression
for LL lysate and 79 and 75% suppression for
phagocyte-depleted cells (Table 5).
Effect of LL lysate on T-lymphocyte-enriched
cells. LL lysate was capable of inducing suppres-
sive activity in the T-lymphocyte-enriched cell
population (Table 6).
DISCUSSION
These experiments demonstrate that leproma-
tous macrophages produce immunosuppressive
factors which could be responsible for the low-
ered cell-mediated immune response observed
in lepromatous patients. We have preliminary
data to show that a sonicate ofM. leprae antigen
TABLE 2. Effect of LL lysate on ConA and PHA stimulation of normal mononuclear cells
cpma
Stimulation of cells Expt
Mean + SEM1
~~~~23 4
Control 1,821 1,790 266 1,292 ± 54
ConA 34,842 40,432 35,235 36,836 ± 1,835
ConA + LL lysate 2,693 1,986 1,552 2,077 + 333
Control 1,821 2,569 2,433 266 1,772 ± 528
PHA 83,610 56,653 69,828 30,538 61,282 ± 10,335
PHA + LL lysate 111,804 55,747 63,054 28,086 64,672 ± 17,422
a Mean of triplicate cultures for columns 1 through 4. For experiments with ConA, P < 0.0025 (comparing
results with and without LL lysate); results of experiments with PHA were not statistically significant.
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TABLE 3. Effect of LL lysate on induction of suppressor cells from mononuclear cellsa
ConA M. leprae
Individuals
supplying cells a cpm in cells: % Suppres- A cpm in cells: % Suppres-
Control Treatedb sionc Control Treated' sionc
Normal 38,236 ± 7,032 14,323 ± 5,012 67 ± 11 4,749 ± 1,125 863 ± 555 86 ± 7
Tuberculoid 31,459 ± 10,003 3,263 ± 1,853 82 ± 11 4,586 ± 1,073 769 ± 541 86 ± 11
Lepromatous 20,129 ± 5,452 3,776 ± 1,414 82 ± 7
a Suppression of ConA and M. leprae responses of mononuclear cells from normal, tuberculoid, and
lepromatous people. All values show means ± standard errors of the mean.
b Preincubated in LL lysate.
c Calculated as [1 - (counts per minute of treated cells/counts per minute of control)] x 100.
had stimulatory capacity similar to that of whole
M. leprae. The ability of M. leprae lysates to
inhibit whole M. Ieprae-induced proliferation
may give information to determine whether the
factor is bacterial or derived from the host cell.
However, the results presented in Table 1 and
Fig. 1 for normal and tuberculoid macrophage
lysates and cycloheximide-treated lepromatous
macrophage lysates also give certain indications
whether the lysate is a host cell or a bacterial
product. Lysates prepared from normal and
tuberculoid macrophages exposed to M. leprae
in vitro did not show any inhibitory activity.
These results support the conclusion that the
suppressor factor is not a direct product of M.
leprae. Lysate made from cycloheximide-treat-
ed macrophages and macrophages exposed to
heat-killed M. leprae also do not show any
inhibitory activity. This also favors the possibili-
ty that the observed effects are not due to
bacillary products but most likely are macro-
phage products. C-LL(-ve) lysate showed no
inhibitory action, but the addition of M. leprae
to the macrophage cultures induced the produc-
tion of the suppressor factor. These findings
suggest that an active interaction between the
lepromatous macrophages and the bacilli is re-
quired for the induction of the suppressor factor.
The inhibitor is heat stable and nondialyzable. In
vitro production of this factor was not affected
by concomitant incubation with indomethacin, a
prostaglandin synthetase inhibitor, suggesting
that the factor is not a prostaglandin (data not
shown).
Among the monocyte factors that have sup-
pressor activity are the dialyzable and the heat-
stable factors (5, 27). Furthermore, arginase and
unlabeled thymidine (21) are also immunosup-
pressive in various in vitro systems. Our experi-
ments, in which we have shown that the require-
I
C Ly C Ly C Ly
Normal Tub*rculoid Lepromatous
FIG. 4. Suppression of ConA mitogenic responses of mononuclear cells from normal, tuberculoid, and
lepromatous groups. Cells pretreated for 24 h with LL lysate were added to autologous cells and exposed to
mitogen. Each value is the mean counts per minute of triplicate cultures. Values are shown for cells pretreated
with LL lysate (Ly) and for untreated control cells (C).
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FIG. 5. Suppression of M. leprae responses of pe-
ripheral blood mononuclear cells from normal and
tuberculoid groups. Cells pretreated for 24 h with LL
lysate were added to autologous cells and exposed to
M. leprae. Each value is the mean counts per minute
of triplicate cultures from each individual. Values are
shown for cells pretreated with LL lysate (Ly) and for
untreated control cells (C).
ment of lysate in the initial hours of culture
generates suppressor activity, may rule out the
possibility that thymidine or arginase is involved
in the suppression.
Another interesting observation in our study
was the specificity of action of the lysate. A
lepromatous patient who is in the early and very
active stages of the disease may be anergic to
mitogens and a host of antigens, including M.
leprae (3, 19). This correlates with our observa-
tion that mitogenic and antigenic stimulation of
TABLE 4. Suppression of ConA response of
mononuclear cells from lepromatous patientsa
cpm
Preincuba- 2nd
tion culture Expt Mean + SEM
2 3
Control None 265 2,158 1,406 1,276 540
ConA 3,532 6,157 2,915 4,201 1,013
LL lysate None 461 2,154 2,723 1,779 692
ConA 400 7,340 4,435 4,058 2,050
a Suppressive activity of mononuclear cells from
lepromatous patients, positive for acid-fast bacilli,
when exposed to LL lysate, as tested in an autologous
system.
TABLE 5. Effect on inhibitory activity of removing
phagocytic cells from suppressor cell populationa
A cpm in cell populations:
Preincubation Normal Tuber- Lep-(2pb culoid roma-(3) tous (2)
Control 31,195 21,880 27,496
LL lysate 13,526 4,070 7,485
(57)C (77) (73)
LL lysate + carbonyl iron 16,151 6,576 6,977
(50) (79) (75)
a Mononuclear cultures exposed to LL lysate were
treated with carbonyl iron to remove phagocytic cells
or were left untreated and were checked for suppres-
sive activity to ConA stimulation in an autologous
system. All cells were subjected to a second culture in
ConA.
b Numbers in parentheses show numbers of experi-
ments.
c Numbers in parentheses show percentages of sup-
pression, calculated as [1 - (counts per minute of
treated sample/counts per minute of control)] x 100.
normal mononuclear cells was inhibited by LL
lysate. However, normal lymphocyte prolifera-
tion mediated by M. vaccae, M. bovis BCG,
PPD, and (to a certain extent) ICRC was not
inhibited by LL lysate. These antigens may
somehow overcome the suppressive action of
the lysate. At this stage we do not know the
exact mechanisms involved.
Several studies have emphasized a crucial role
for macrophages in regulating T-cell-dependent
reactivities (10, 23). First, macrophages may be
required to present antigens or mitogens to T
cell recognition units in a manner required for T
cell activation. Second, macrophages may mod-
ulate T cell reactivity through the liberation of
soluble immunoregulatory molecules. These sol-
TABLE 6. Effect of LL lysate on T-lymphocyte-
enriched normal mononuclear cellsa
A cpm in expt:
Preincubation
1 2
Control 38,225 42,019
LL Lysate
Mononuclear cells 6,433 (83)b 9,316 (78)
T-lymphocyte-enriched 6,384 (83) 8,122 (81)
cells
a Whole mononuclear cells or T-lymphocyte-en-
riched cells were pretreated with LL lysate for 24 h
and tested for suppressive activity to ConA stimula-
tion in an autologous system.
b Numbers in parentheses indicate percentage of
suppression, calculated as explained in Table 5, foot-
note c.
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uble products may exert a direct effect on re-
sponding T cells. Alternatively, as the data
presented here suggest, some immunoregulatory
material liberated by macrophages may indirect-
ly affect responding T cell subsets. The studies
presented here indicate that the macrophage or
its products and T cell interaction is required to
generate suppression. Although this circular in-
teraction between macrophages and T cells may
seem unduly complicated, it is consistent with
the known complexities of cell interaction orig-
inally proposed by Jerne (13).
Cells treated with carbonyl iron after the
induction phase still showed suppressive activi-
ty to ConA stimulation. These results suggest
that the suppressor cell induced in vitro is a
lymphocyte. T lymphocyte enrichment methods
show that the suppressor lymphocyte is a T cell.
However, further enrichment methods for T
lymphocytes and T suppressor lymphocytes are
in progress. The action of the suppressor cells
generated in vitro was nonspecific in its action
as it inhibited both ConA and M. leprae stimula-
tion.
In other experiments, we have shown that the
lysate also inhibits certain macrophage functions
(manuscript in preparation). Taking all the
above data into consideration, we hypothesize
that in vitro, macrophages of the susceptible
individual infected with M. leprae produce im-
munosuppressors which act nonspecifically and
systemically by altering macrophages and T
lymphocytes. Huchet and Florentine (12) have
suggested that a low dose of M. bovis BCG
would mainly favor the induction of suppressor
macrophages, whereas larger doses could lead
to the induction of T cells in addition. Mehra et
al. (18) have also reported that M. Ieprae-in-
duced suppression in vitro was produced by an
adherent cell and an E rosetting cell. Over and
above the T-suppressor cells induced by lepro-
min, the presence of these cells in lepromatous
patients in the above study could be due to in
vivo activation of T cells by certain products
released from the monocyte. The authors do
show the presence of adherent suppressor cells
in vitro also.
These experiments are important in our un-
derstanding of the abnormal immune responses
in mycobacterial diseases. They could indicate a
central role for both macrophages and T cells.
Adherent cells of patients with disseminated
fungal infection released a soluble factor that
was capable of inhibiting the blastogenic re-
sponse of normal T cells, probably by generating
T-suppressor cells (25). Further, in experimental
malaria and Trypanosoma brucei infection, both
macrophages and T cells have been shown to be
affected by the parasites, resulting in immunode-
pression (7, 16).
In leprosy, which presents a complex disease
spectrum, there may well be more than one
immunological mechanism operative in regula-
tion of the immune response to leprosy bacilli.
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